The EU-funded HEDIMED project started in 2020 investigating the role of the exposome in immune-mediated diseases, specifically asthma and allergies, celiac disease, and type 1 diabetes. The exposome describes all the exposures of an individual in a lifetime and how those exposures relate to health starting before birth. The exposome includes areas of exposure such as the environment, diet and lifestyle, pollution, and occupational sources. HEDIMED examined an extensive clinical sample of pregnant women and children, using complete genetic and molecular profiling (omics) and data mining to create open access tools that advance solutions for this growing public health challenge.
The HEDIMED team will present the key outcomes of the project and address scientific, technological and policy aspects of exposome research.
Program
09:00 - 10:50 Welcome and science talks
- From environment to immunity: bridging the gap in disease mechanism research
- Exposomic insights into immune mediated diseases: risk factors, causes, mechanisms
- Common exposomic determinants of immune-mediated diseases
10:50 - 12:00 Innovative technologies and platforms for exposome research
- Allergens Screening Tool: Portable Fluorescence Biosensing Reader
- The HEDIMED research platform – virtual and scalable data analytics
- The HEDIMED public platform – data visualisation and dissemination for researchers
12:00 - 12:45 Lunch break
12:45 - 13:15 Policy-related insights related to Celiac Disease, Type 1 Diabetes and Allergies
- Open-source simulation and population dynamic models for immune-mediated diseases
13:15 - 14:45 Panel discussion: “How exposomic insights can shape policies and public health”
14:45 - 15:00 Wrap up and closing remarks
Speakers
Heikki Hyöty, Tampere University
Aki Sinkkonen, Natural Resources Institute Finland
Ketil Størdal, University of Oslo
Gabriele Berg, TU Graz
Loïc Burr, CSEM
Siliva Demuru, CSEM
Juha Pajula, VTT
Petri Saviranta, VTT
Apostolia Karabatea, Gnomon Informatics
Jani Mäkinen, Tampere University
Jutta Laiho, Tampere University
Hanna Haveri, Wellbeing services county of Päijät-Häme
Kalle Kurppa, Tampere University
Tiina Vitikainen, The Finnish Allergy, Skin and Asthma Federation
We hope to engage with you to further extend the impact of our work. Join us online for an inspiring day of learning about the exposome, its impact on immune-mediated diseases, and exchange perspectives with researchers and experts from our consortium, as well as other invited European stakeholders.
After registering, you will receive a link for the webinar.